114 related articles for article (PubMed ID: 8809479)
21. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
22. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
[TBL] [Abstract][Full Text] [Related]
23. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
24. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer.
Ohgami A; Mitsudomi T; Sugio K; Tsuda T; Oyama T; Nishida K; Osaki T; Yasumoto K
Ann Thorac Surg; 1997 Aug; 64(2):363-7. PubMed ID: 9262576
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Shariat SF; Roudier MP; Wilcox GE; Kattan MW; Scardino PT; Vessella RL; Erdamar S; Nguyen C; Wheeler TM; Slawin KM
Cancer Res; 2003 Aug; 63(15):4662-70. PubMed ID: 12907647
[TBL] [Abstract][Full Text] [Related]
26. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
Putz E; Witter K; Offner S; Stosiek P; Zippelius A; Johnson J; Zahn R; Riethmüller G; Pantel K
Cancer Res; 1999 Jan; 59(1):241-8. PubMed ID: 9892213
[TBL] [Abstract][Full Text] [Related]
28. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.
de Manzoni G; Pelosi G; Pavanel F; Di Leo A; Pedrazzani C; Durante E; Cordiano C; Pasini F
Br J Cancer; 2002 Apr; 86(7):1047-51. PubMed ID: 11953846
[TBL] [Abstract][Full Text] [Related]
29. The impact of bone marrow micrometastases on metastatic disease-free survival in patients with colorectal carcinoma.
O'Connor OJ; Cahill RA; Kirwan WO; Redmond HP
Colorectal Dis; 2005 Jul; 7(4):406-9. PubMed ID: 15932568
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
31. Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.
Cher ML; de Oliveira JG; Beaman AA; Nemeth JA; Hussain M; Wood DP
Clin Cancer Res; 1999 Sep; 5(9):2421-5. PubMed ID: 10499613
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
33. [Molecular approach to detection of micrometastatic prostatic cancer cells in the lymph nodes and the bone marrow].
Deguchi T; Yang M; Nishino Y; Ehara H; Takahashi Y; Kawata Y; Ito S; Ito Y; Doi T
Hinyokika Kiyo; 1996 Oct; 42(10):787-90. PubMed ID: 8951476
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
[TBL] [Abstract][Full Text] [Related]
35. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
36. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence.
Mejean A; Vona G; Nalpas B; Damotte D; Brousse N; Chretien Y; Dufour B; Lacour B; Bréchot C; Paterlini-Bréchot P
J Urol; 2000 Jun; 163(6):2022-9. PubMed ID: 10799250
[TBL] [Abstract][Full Text] [Related]
39. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
40. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant.
Mueller P; Carroll P; Bowers E; Moore D; Cher M; Presti J; Wessman M; Pallavicini MG
Cancer; 1998 Aug; 83(3):538-46. PubMed ID: 9690547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
